These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17690334)

  • 1. Lung dendritic cells elicited by Fms-like tyrosine 3-kinase ligand amplify the lung inflammatory response to lipopolysaccharide.
    von Wulffen W; Steinmueller M; Herold S; Marsh LM; Bulau P; Seeger W; Welte T; Lohmeyer J; Maus UA
    Am J Respir Crit Care Med; 2007 Nov; 176(9):892-901. PubMed ID: 17690334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FMS-like tyrosine kinase 3 ligand aggravates the lung inflammatory response to Streptococcus pneumoniae infection in mice: role of dendritic cells.
    Winter C; Taut K; Länger F; Mack M; Briles DE; Paton JC; Maus R; Srivastava M; Welte T; Maus UA
    J Immunol; 2007 Sep; 179(5):3099-108. PubMed ID: 17709524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No defect in T-cell priming, secondary response, or tolerance induction in response to inhaled antigens in Fms-like tyrosine kinase 3 ligand-deficient mice.
    Walzer T; Brawand P; Swart D; Tocker J; De Smedt T
    J Allergy Clin Immunol; 2005 Jan; 115(1):192-9. PubMed ID: 15637568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FMS-like tyrosine kinase 3 ligand treatment of mice aggravates acute lung injury in response to Streptococcus pneumoniae: role of pneumolysin.
    Brumshagen C; Maus R; Bischof A; Ueberberg B; Bohling J; Osterholzer JJ; Ogunniyi AD; Paton JC; Welte T; Maus UA
    Infect Immun; 2012 Dec; 80(12):4281-90. PubMed ID: 23006850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of FLT3 signaling targets conventional dendritic cells to attenuate acute lung injury.
    Dong L; He HL; Lu XM; Yang Y; Qiu HB
    APMIS; 2012 Oct; 120(10):808-18. PubMed ID: 22958289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia.
    Herold S; Tabar TS; Janssen H; Hoegner K; Cabanski M; Lewe-Schlosser P; Albrecht J; Driever F; Vadasz I; Seeger W; Steinmueller M; Lohmeyer J
    Am J Respir Crit Care Med; 2011 May; 183(10):1380-90. PubMed ID: 21278303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effects of inhaled nitric oxide are optimized at lower oxygen concentration in experimental Klebsiella pneumoniae pneumonia.
    Sun Z; Sun B; Wang X; Wang W; Zhu L
    Inflamm Res; 2006 Oct; 55(10):430-40. PubMed ID: 17109070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells.
    Zhan Y; Vega-Ramos J; Carrington EM; Villadangos JA; Lew AM; Xu Y
    Eur J Immunol; 2012 Nov; 42(11):2889-900. PubMed ID: 22806691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo administration of Fms-like tyrosine kinase-3 ligand effectively stimulates lung dendritic cell expansion in mice.
    Wang HW; Lu JY; Wang L; Tian G
    Chin Med J (Engl); 2012 Jul; 125(14):2562-7. PubMed ID: 22882940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y; Huang H; Chen Z; Zong L; Xiang J
    J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SK-126, a synthetic compound, regulates the production of inflammatory cytokines induced by LPS in antigen-presenting cells.
    Kang K; Kim H; Kim KI; Yang Y; Yoon DY; Kim JH; Ryu JH; Noh EJ; Jeon SD; Lim JS
    Biochem Pharmacol; 2008 Mar; 75(5):1054-64. PubMed ID: 18054895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
    Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH
    J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo IL-18 supplementation ameliorates lethal acute lung injury in burn-primed endotoxemic mice: a novel anti-inflammatory role of IL-18.
    Sekine K; Fujishima S; Sasaki J; Ishizaka A; Aiso S; Aikawa N
    Shock; 2009 Nov; 32(5):554-62. PubMed ID: 19197224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection.
    Ye P; Garvey PB; Zhang P; Nelson S; Bagby G; Summer WR; Schwarzenberger P; Shellito JE; Kolls JK
    Am J Respir Cell Mol Biol; 2001 Sep; 25(3):335-40. PubMed ID: 11588011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of induction of pneumonia in mice with planktonic and biofilm cells of Klebsiella pneumoniae.
    Sharma S; Mohan H; Sharma S; Chhibber S
    Microbiol Immunol; 2011 May; 55(5):295-303. PubMed ID: 21272064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect of thalidomide alone or in combination with augmentin in Klebsiella pneumoniae B5055 induced acute lung infection in BALB/c mice.
    Kumar V; Chhibber S
    Eur J Pharmacol; 2008 Sep; 592(1-3):146-50. PubMed ID: 18662682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia.
    Greenberger MJ; Strieter RM; Kunkel SL; Danforth JM; Goodman RE; Standiford TJ
    J Immunol; 1995 Jul; 155(2):722-9. PubMed ID: 7608550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute alcohol intoxication suppresses the interleukin 23 response to Klebsiella pneumoniae infection.
    Happel KI; Odden AR; Zhang P; Shellito JE; Bagby GJ; Nelson S
    Alcohol Clin Exp Res; 2006 Jul; 30(7):1200-7. PubMed ID: 16792568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice.
    Tsai WC; Strieter RM; Wilkowski JM; Bucknell KA; Burdick MD; Lira SA; Standiford TJ
    J Immunol; 1998 Sep; 161(5):2435-40. PubMed ID: 9725241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor necrosis factor-alpha therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury.
    Moore TA; Lau HY; Cogen AL; Monteleon CL; Standiford TJ
    Shock; 2003 Oct; 20(4):309-15. PubMed ID: 14501943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.